Since APOE genotype is a major risk for AD and is strongly associated with cardiovascular diseases [47], future studies including this information with longitudinal design may elucidate the temporal relationship and the complex interaction among atherosclerotic disease, AD neuropathology, and brain structural changes in OSA patients. The gene discussed is APOE; the disease is cardiovascular disorder.